At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.
Company Details
- Founded
- -
- Address
- New York, New York
- Industry
- Biotechnology
- Website
- bioharmonytherapeutics.com
- Keywords
- Merion Station.
- HQ
- New York, New York
Bioharmony Therapeutics Questions
Bioharmony Therapeutics's website is bioharmonytherapeutics.com
Bioharmony Therapeutics's LinkedIn profile is https://www.linkedin.com/company/bioharmony-therapeutics
Bioharmony Therapeutics's industry is
Biotechnology
Bioharmony Therapeutics's top competitors are
Lucerna, Inc.,
Progenra, Inc.,
Buckle Therapeutics Inc.,
Quark Pharmaceuticals,
Be Therapeutics,
Aspa Therapeutics,
Akari Therapeutics, Plc,
Clearfield Partners,
Emily's Entourage,
Statadx.
Bioharmony Therapeutics's categories are Biotechnology
Bioharmony Therapeutics's founding year is 2016
